Thomas Jonassen
Vermogen: 5 M $ op 31-05-2026
Vermogen: 5 M $ op 31-05-2026
Thomas Jonassen is the founder.
Dr. Jonassen was the founder of Action Pharma A, founded in 2000, holding the title of Chief Scientific Officer.
Dr. Jonassen is also the founder of TXP Pharma GmbH,ResoTher Pharma AS.
Dr. Jonassen is currently an Associate Professor at the University of Copenhagen and the Chief Scientific Officer at SynAct Pharma AB starting in 2024.
Dr. Jonassen holds a doctorate from the University of Copenhagen.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
SYNACT PHARMA AB 4,77% | 19-12-2025 | 2.545.320 ( 4,77% ) | 5 M $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| SYNACT PHARMA AB | Hoofd Techniek/Wetenschap/O&O | - |
University of Copenhagen
University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
ResoTher Pharma AS
ResoTher Pharma AS Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops peptide-based drugs | Oprichter | - |
| Bedrijven | Functie | Einde |
|---|---|---|
TXP Pharma GmbH | Oprichter | - |
Action Pharma A/S
Action Pharma A/S BiotechnologyHealth Technology Manufactures biopharmaceutical products | Oprichter | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
University of Copenhagen
University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Action Pharma A/S
Action Pharma A/S BiotechnologyHealth Technology Manufactures biopharmaceutical products | Health Technology |
SynAct Pharma AB
SynAct Pharma AB Pharmaceuticals: MajorHealth Technology Provides pharmaceutical drugs for treatment inflammatory diseases | Health Technology |
TXP Pharma GmbH | |
ResoTher Pharma AS
ResoTher Pharma AS Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops peptide-based drugs | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau